Marcin Frąckiewicz

Marcin Frąckiewicz is the founder and CEO of TS2 Space, a satellite communications company serving customers around the world. A graduate of the Warsaw School of Economics (SGH), he has more than two decades of experience in telecommunications, satellite services and technology ventures. He writes about satellite communications, space technology, artificial intelligence and the stock market, with a particular focus on technology companies, semiconductors, emerging industries and the trends shaping global innovation. Follow Marcin Frąckiewicz on Google News, Facebook. or Linkedin.

Silver Near $50 – Is a New Record Imminent? Inside 2025’s Soaring Silver Surge

Silver Price Today, 8 November 2025: XAG/USD Holds Near $48.3 as Markets Consolidate Below $50

Spot silver is hovering around the $48.3–$48.5/oz area this weekend, keeping the metal in a tight range just under the psychologically important $50 level. Friday’s New York session settled near $48.34, with an intraday range roughly $47.95–$48.90. Weekend OTC quotes vary slightly by source and typically see thinner liquidity. Silver Price+2Investing.com+2
8 November 2025
··
Tesla Stock Today (Nov 7, 2025): TSLA Slides After Shareholders Approve Elon Musk’s $1 Trillion Pay Package

Tesla Stock Today (Nov 7, 2025): TSLA Slides After Shareholders Approve Elon Musk’s $1 Trillion Pay Package

Summary: Tesla shares fell on Friday as Wall Street digested the historic shareholder vote to approve CEO Elon Musk’s new, performance‑based compensation plan. The package—headlined at $1 trillion—passed with more than 75% support at Tesla’s annual meeting on November 6. TSLA closed down 3.68% at $429.52, extending a two‑day decline to roughly 7%. Reuters
8 November 2025
···
Oracle (ORCL) Stock Rockets 70% on AI Frenzy – Jim Cramer Warns “It’s the Only One I’m Worried About”

Oracle (ORCL) Stock Today, Nov. 7, 2025: $239 Close as $18B AI Data‑Center Financing and Oracle‑Linked Cyber Breach Dominate the Tape

Summary: Oracle shares slipped again on Friday, closing at $239.26 after a fresh round of headlines: Reuters reported an $18 billion bank loan tied to a New Mexico data‑center campus associated with Oracle and the broader “Stargate” AI infrastructure push, while The Washington Post disclosed it was among the victims of a cyber breach linked to Oracle E‑Business Suite. Oracle also announced a new health‑AI collaboration with the Cancer Center Informatics Society. Oracle+3StockAnalysis+3Reuters+3
8 November 2025
····
Palantir (PLTR) Edges Lower on Nov. 7 as Insider Sale Surfaces—Analysts Lift Targets After Blowout Q3

Palantir Stock Today (Nov. 7, 2025): PLTR Ends Week Higher as New Partnerships With Stagwell and Valoriza Offset AI-Sector Jitters

Palantir Technologies finished Friday at $177.93, up +1.65% on the day, recovering from sharp midweek volatility tied to a broader pullback in artificial‑intelligence names. Intraday, PLTR traded between $168.91 and $178.70 on heavy volume. The rebound followed a flurry of corporate headlines on Nov. 6–7, including two new commercial partnerships and high‑profile remarks from CEO Alex Karp. Reuters
8 November 2025
···
Beyond Meat Stock Implodes: 60% Crash After Shocking Debt-For-Equity Swap

Beyond Meat (BYND) Jumps 16.8% as Company Moves Q3 Results to Nov. 10 After NT 10‑Q Filing

Summary: Beyond Meat’s stock staged a sharp rebound on Friday, November 7, after the company said it will publish third‑quarter results on Monday, November 10, a day earlier than previously indicated. The announcement came alongside an NT 10‑Q filing disclosing an expected material, non‑cash impairment and a material weakness in internal controls—two developments that have dominated trading since Thursday. GlobeNewswire+1
8 November 2025
··
You Won’t Believe What Google Did This Month: July 2025’s Biggest Stories

Google Stock Today (7 Nov 2025): Alphabet (GOOGL, GOOG) slips as investors weigh YouTube–Disney carriage fight, new AI data‑center plan, and Europe expansion

Alphabet shares eased on Friday while a flurry of headlines from 6–7 November kept the stock in focus—from YouTube’s public carriage dispute with Disney to fresh data‑center plans in Australia and an upcoming “largest‑ever” investment announcement in Germany. Here’s the full wrap and what it means for GOOGL/GOOG.
8 November 2025
···
Tech Stocks Storm the Market: QQQ Rockets on Trade Truce while TQQQ Investors Cash In (Oct 14, 2025)

QQQ vs. QQQM vs. VGT on Nov. 7, 2025: After Tech’s Worst Week Since April, Which ETF Still Looks Best?

The tech trade just hit a speed bump. The Nasdaq-100’s big 2025 rally cooled this week as investors took profits in AI leaders, handing the tech complex its worst weekly drop since April. The Invesco QQQ Trust closed Friday at $609.74, down about 3.1% from last Friday’s close—yet still well above summer levels and not far from its Oct. 29 all‑time high close near $636. Investing.com
8 November 2025
·····
BP Stock Soars as Oil Rally and Strategic Shift Boost Investor Confidence

BP Stock Today (7 November 2025): ADR Hits 52‑Week High as Buybacks Continue; Oil Steadies and Brokers Weigh In

Summary: BP’s U.S. ADR set a fresh 52‑week high on Friday as the company pressed ahead with daily share repurchases and crude prices stabilized into the weekend. Broker commentary during 6–7 November stayed constructive, while London filings confirmed chunky buybacks across both days. Reuters+4MarketWatch+4Investegate+4
8 November 2025
···
1 … 222 223 224 225 226 … 409

Stock Market Today

  • Revolution Medicines (RVMD) Shares Trade at a Premium Despite Robust Gains
    July 25, 2026, 2:47 PM EDT. Revolution Medicines (RVMD) shares have jumped with a 399.2% return over the past year and approximately 6.4x growth in three years, though the stock's valuation is considered steep. With a P/B ratio of 26.8x, Revolution Medicines is well above the Biotech sector's 2.5x average and peer level of 10.3x. The stock meets just 2 out of 6 valuation criteria, indicating a premium linked to its FDA-reviewed drug daraxonrasib and data from its pancreatic cancer trial, along with concerns tied to regulatory risk.